Fisons Plc FISN.L> strong international growth main feature group's 1986 progress pharmaceutical division reporting 50 pct increase U.S. Sales period. The rise due sustain marketing programme large sale force introduction aerosol form Intal anti-asthma drug push U.S. Sales 70 pct. The company comment 1986 result pre-tax profit rise 85.1 mln stg 72.3 mln 1985. The result line market forecast share nevertheless ease fall market 634p 0857 GMT 643p. Fisons potential future growth Intral Opticrom Nasalcrom product clearly indicate strong 1986 performance. The scientific equipment raise proportion technology product manufacture raise ability generate high margins. The horticulture operation demonstrate outstanding marketing ability. Underlying cash flow operation positive despite full programme capital investment. Action protect foreign currency movement result net gain profits. REUTER 